Survey: U.S. patient groups have low opinion of drugmaker marketing ethics

04/8/2013 |

Half of 70 U.S.-based patient groups surveyed said drugmakers are innovative, and 59% said drugmakers are good or excellent at creating high-quality, useful products. But 76% said drugmakers have fair or poor ethics in marketing, and only 10% said the industry is transparent. In the U.K., 70% of 80 patient groups surveyed rated drugmakers as good or excellent at making high-quality, useful products and 72% rated ethics in industry marketing as fair or poor.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC